Results 331 to 340 of about 122,153 (397)

Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France. [PDF]

Fundam Clin Pharmacol
Laroche ML, Labetoulle M, Jouanjus E, Kröger E, Zongo A.   +4 more
europepmc   +1 more source

Nicotinic Receptors in the Medial Habenula to Interpeduncular Nucleus Pathway: Modulators of Reward, Aversion and Emotion

European Journal of Neuroscience, Volume 62, Issue 11, December 2025.
ABSTRACT The medial habenula–interpeduncular nucleus pathway is a highly conserved and densely innervated brain circuit known for its unique cholinergic transmission and exceptional expression of nicotinic acetylcholine receptors. This pathway plays a critical role in regulating motivational and emotional processes, particularly those related to ...
Maria Ciscato, Mathilde Chouvaeff, Alexandre Mourot   +2 more
wiley   +1 more source

An approximation to the interaction of deca-2E,6Z,8E-trienoic acid isobutylamide with cannabinoid CB2 receptor

, 2019
Alejandro Olmos, Alberto Flores-García, Marco Cajero-Juárez, Z. Hernández-Gallegos, Mauro M. Martínez-Pacheco   +4 more
openalex   +1 more source

Cannabinoids in Chronic Pain: Clinical Outcomes, Adverse Effects and Legal Challenges. [PDF]

Neurol Int
Sic A, George C, Gonzalez DF, Tseriotis VS, Knezevic NN.   +4 more
europepmc   +1 more source

Acute or Chronic β‐Caryophyllene Systemic Administration in Healthy Adult Male Mice Does Not Modulate Anxiety‐Like Extinction Behavior Induced by Subsequent Re‐Exposure to 3D Maze

Fundamental &Clinical Pharmacology, Volume 39, Issue 6, December 2025.
ABSTRACT Pharmacotherapy for major anxiety disorders continues to present dangerous side effects, complicating precise treatment choices for each patient. In this context, β‐caryophyllene (BCP), a selective agonist of the cannabinoid type II receptor (CB2R), is recognized as a safe immunomodulatory drug.
Rayan Fidel Martins Monteiro, Marcos Vinícius Lebrego Nascimento, Klinsmann Thiago Lima, Valdina Solimar Lopes Cardoso, José Ramon Gama Almeida, Wellington Junior Taisho Nagahama Costa, Anderson Valente‐Amaral, Bruno Eduardo Godinho Teixeira, Ludmila Santos‐Barbosa, Vinicius Teles Shirakura, Gilmara de Nazareth Tavares Bastos   +10 more
wiley   +1 more source

Research Review: What we have learned about the endocannabinoid system in developmental psychopathology

Journal of Child Psychology and Psychiatry, Volume 66, Issue 12, Page 1904-1915, December 2025.
Background The endocannabinoid (eCB) system, the primary target of cannabis, has gained significant attention as a potential novel therapeutic approach for treating a range of psychiatric disorders characterized by dysregulation of stress, emotion, and social behavior.
Ryann C. Tansey, Marc D. Ferger, Hilary A. Marusak, Leah M. Mayo   +3 more
wiley   +1 more source

Beyond clinical trials: Extending the role of the clinical research nurse into social care and homeless research

Journal of Clinical Nursing, Volume 34, Issue 12, Page 5375-5383, December 2025.
Abstract Aim Clinical research nurses work at the fulcrum of clinical trials with clearly defined roles and responsibilities. In England, the National Institute for Health Research (the main funder of health research) has broadened its scope to encompass social care research.
Elizabeth Biswell R, Michael Clark, Michela Tinelli, Gillian Manthorpe, Joanne Neale, Martin Whiteford, Michelle Cornes   +6 more
wiley   +1 more source

Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines. [PDF]

Pharmaceuticals (Basel)
Vitetta L, Henson JD, Hayes E, Rutolo D, Hall S.   +4 more
europepmc   +1 more source

Potential Antimicrobial Use of Cannabidiol in Dentistry: A Scoping Review. [PDF]

Dent J (Basel)
Mederos M, Elizalde-Hernández A, Francia A, Chisini LA, Isolan CP, Moraes RR, Lund RG, David C.   +7 more
europepmc   +1 more source

Considering the Effects of Cannabinoids and Exercise on the Brain: A Narrative Review. [PDF]

Sports (Basel)
Rajaei AY, Neary JP, Thompson ES, Singh J, Mang CS.   +4 more
europepmc   +1 more source